Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Kinase target as stroke target

March 20, 2019

First subject dosed in phase II study of GRF-6019 in patients with severe Alzheimer's disease

March 19, 2019

ACADIA Pharmaceuticals presents 5-HT2A receptor ligands

March 19, 2019

Asceneuron discloses OGA inhibitors

March 19, 2019

Clotting protein cuts neuromuscular synapses, if it can

March 19, 2019

New model explains neural basis of alternating bilateral sensory stimulation for fear disorders

March 19, 2019

New phase II trial assesses TLC-590 for postsurgical pain management following bunionectomy

March 18, 2019

PK/PD evaluation of a single dose of nilotinib in Parkinson's disease patients

March 18, 2019

Stroke candidate pyragrel safe and well tolerated in phase I study

March 18, 2019

Phase I/II study planned for ACT-107 after first-in-human results show safety

March 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...
Menstrual ‘footprints’ may act as broad personal health markers
BioWorld
WAVES, an algorithm designed to extract menstrual-cycle metrics from physiological signals such as basal body temperature, which oscillates with sex hormones,...